Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2016

01-02-2016 | Research Article

Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers

Authors: Teddy Novais, Antoine Duclos, Remi Varin, Isabelle Lopez, Valérie Chamouard

Published in: International Journal of Clinical Pharmacy | Issue 1/2016

Login to get access

Abstract

Background Replacement therapy in haemophilia plays an important role in the effective management of this rare bleeding disorder and requires a high level of knowledge and practical skills. Objective To evaluate and to compare the knowledge and skills about the medicines and their management among people with haemophilia treated with clotting factor concentrates, and their informal caregivers. Setting Eight Hospital Pharmacies working closely with Haemophilia Care Centres in France. Method In this cross-sectional and multi-centre study, 26-item questionnaire was specifically developed to assess the knowledge and skills. Face-to-face interviews using a questionnaire were conducted with patients and caregivers. Main outcome measure Level of knowledge and skills about disease, treatment and medication management. Results This study included 80 patients and 55 caregivers. Although most interviewees had basic knowledge of the treatment, only 43.7 % knew the effect of clotting factor concentrates on the haemostasis process. Similarly, only 12.7 % of the patients and 30.9 % of the caregivers referred to inhibitors as adverse effects. Despite intensive training for home treatment, 55.7 % reported difficulties with reconstitution or injection. The knowledge required for the responsible management of their medications had not been totally acquired: only 17 participants were indeed familiar with the medication storage conditions; 29 patients and 9 caregivers had already experienced an emergency which they had to treat with no medicine available at home; and 47.4 % of participants had already thrown away an unused drug vial. Conclusion This study shows the need of a regular update and to renew awareness of haemophilia treatment specificities among these populations. The identified needs suggest that we should more invest in educational techniques or therapeutic education programs more focused on medication management.
Appendix
Available only for authorised users
Literature
1.
go back to reference O’Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost. 2005;31(5):561–8.CrossRefPubMed O’Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost. 2005;31(5):561–8.CrossRefPubMed
2.
go back to reference Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010;8(6):1256–65.CrossRefPubMed Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010;8(6):1256–65.CrossRefPubMed
3.
go back to reference Makris M, Calizzani G, Fischer K, Gilman EA, Hay CRM, Lassila R, et al. EUHASS: the European haemophilia safety surveillance system. Thromb Res. 2011;127(Suppl 2):S22–5.CrossRefPubMed Makris M, Calizzani G, Fischer K, Gilman EA, Hay CRM, Lassila R, et al. EUHASS: the European haemophilia safety surveillance system. Thromb Res. 2011;127(Suppl 2):S22–5.CrossRefPubMed
4.
go back to reference Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, et al. Thirty years of hemophilia treatment in the Netherlands, 1972–2001. Blood. 2004;104(12):3494–500.CrossRefPubMed Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, et al. Thirty years of hemophilia treatment in the Netherlands, 1972–2001. Blood. 2004;104(12):3494–500.CrossRefPubMed
5.
go back to reference Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med. 1970;283(19):1011–5.CrossRefPubMed Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med. 1970;283(19):1011–5.CrossRefPubMed
6.
go back to reference Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, Fischer K. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia. 2012;18(4):516–20.CrossRefPubMed Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, Fischer K. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia. 2012;18(4):516–20.CrossRefPubMed
7.
go back to reference Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia. 2013;19(3):355–61.CrossRefPubMed Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia. 2013;19(3):355–61.CrossRefPubMed
8.
go back to reference Lindvall K, Colstrup L, Wollter I-M, Klemenz G, Loogna K, Grönhaug S, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia. 2006;12(1):47–51.CrossRefPubMed Lindvall K, Colstrup L, Wollter I-M, Klemenz G, Loogna K, Grönhaug S, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia. 2006;12(1):47–51.CrossRefPubMed
9.
go back to reference De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia. 2008;14(5):931–8.CrossRefPubMed De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia. 2008;14(5):931–8.CrossRefPubMed
10.
go back to reference Nilson J, Schachter C, Mulder K, Hahn M, Steele M, Hilliard P, et al. A qualitative study identifying the knowledge, attitudes and behaviours of young men with mild haemophilia. Haemophilia. 2012;18(3):e120–5.CrossRefPubMed Nilson J, Schachter C, Mulder K, Hahn M, Steele M, Hilliard P, et al. A qualitative study identifying the knowledge, attitudes and behaviours of young men with mild haemophilia. Haemophilia. 2012;18(3):e120–5.CrossRefPubMed
11.
go back to reference Simmons GM, Frick N, Wang A, Miller ME, Fragueiro D. Identifying information needs among children and teens living with haemophilia. Haemophilia. 2014;20(1):1–8.CrossRefPubMed Simmons GM, Frick N, Wang A, Miller ME, Fragueiro D. Identifying information needs among children and teens living with haemophilia. Haemophilia. 2014;20(1):1–8.CrossRefPubMed
12.
go back to reference Khair K, Meerabeau L, Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18(5):1105–13.CrossRefPubMed Khair K, Meerabeau L, Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18(5):1105–13.CrossRefPubMed
13.
go back to reference Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè M-C, Vassilief D, Lopez I, et al. Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications. Haemophilia. 2004;10(5):572–81.CrossRefPubMed Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè M-C, Vassilief D, Lopez I, et al. Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications. Haemophilia. 2004;10(5):572–81.CrossRefPubMed
14.
go back to reference El Dakhakhny AM, Hesham MA, Hassan TH, El Awady S, Hanfy MM. Impact of health instructions on improving knowledge and practices of haemophilia A adolescents: a single centre experience. Haemophilia. 2014;20(4):e260–6.CrossRefPubMed El Dakhakhny AM, Hesham MA, Hassan TH, El Awady S, Hanfy MM. Impact of health instructions on improving knowledge and practices of haemophilia A adolescents: a single centre experience. Haemophilia. 2014;20(4):e260–6.CrossRefPubMed
15.
go back to reference Mulders G, de Wee EM, Vahedi Nikbakht-Van de Sande MCVM, Kruip MJHA, Elfrink EJ, Leebeek FWG. E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial. Haemophilia. 2012;18(5):693–8.CrossRefPubMed Mulders G, de Wee EM, Vahedi Nikbakht-Van de Sande MCVM, Kruip MJHA, Elfrink EJ, Leebeek FWG. E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial. Haemophilia. 2012;18(5):693–8.CrossRefPubMed
16.
go back to reference Lindvall K, Colstrup L, Loogna K, Wollter I, Grönhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia. 2010;16(4):592–6.PubMed Lindvall K, Colstrup L, Loogna K, Wollter I, Grönhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia. 2010;16(4):592–6.PubMed
17.
go back to reference Duncan N, Roberson C, Lail A, Donfield S, Shapiro A. A haemophilia disease management programme targeting cost and utilization of specialty pharmaceuticals. Haemophilia. 2014;20(4):519–26.CrossRefPubMed Duncan N, Roberson C, Lail A, Donfield S, Shapiro A. A haemophilia disease management programme targeting cost and utilization of specialty pharmaceuticals. Haemophilia. 2014;20(4):519–26.CrossRefPubMed
18.
go back to reference Furmedge J, Lima S, Monagle P, Barnes C, Newall F. “I don’t want to hurt him”. Parents’ experiences of learning to administer clotting factor to their child. Haemophilia. 2013;19(2):206–11.CrossRefPubMed Furmedge J, Lima S, Monagle P, Barnes C, Newall F. “I don’t want to hurt him”. Parents’ experiences of learning to administer clotting factor to their child. Haemophilia. 2013;19(2):206–11.CrossRefPubMed
Metadata
Title
Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers
Authors
Teddy Novais
Antoine Duclos
Remi Varin
Isabelle Lopez
Valérie Chamouard
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0207-z

Other articles of this Issue 1/2016

International Journal of Clinical Pharmacy 1/2016 Go to the issue